comprehensive -WSS

comprehensive

author：comprehensive 2025-10-01 12:34:53 - browse：591

green electrocardiogram scan. -- health tech coverage from STAT — Adobe

As Bristol Myers Squibb works to build its treatment for a heart condition that can cause difficulty breathing into a blockbuster drug, it’s propped up an algorithm designed to help find more people who are affected.

The algorithm, which is part of software developed by Viz.ai, earlier this month received clearance from the Food and Drug Administration. The tool, called Viz HCM, looks at 12-lead electrocardiograms collected during routine care and flags suspected cases of hypertrophic cardiomyopathy, or HCM, for further evaluation. As part of a multi-year agreement between the companies, BMS — whose drug, Camzyos, is used to treat HCM — provided funding and scientific input for the development of the algorithm.

“BMS has a vested interest in finding more patients with HCM,” said Matthew Martinez, a cardiologist who leads Viz.ai’s HCM medical advisory board. “Why? Because they’re so philanthropic? No, they want to sell more drugs. They want to help more people by identifying more people.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

WSS

Hospital chaplains balance Covid safety with patients’ spiritual needs

Physician assistants need a new name. Here's what it should be

Profiling embryos to choose those with higher IQs is almost a reality

Beyond aggravation: Constipation is an American epidemic

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

leisure time

comprehensive

entertainment

Medical leaders decry Supreme Court decision on affirmative action

At JPM 2024, hospital systems pitch financial strength to investors

Moonlake's readout produced a cash windfall. Risks remain

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

United colonoscopy coverage change 'may cost lives,' doctors say

The Bio Revolution is changing business and society

Medicare details structure of new drug price negotiation program

Life science postdocs should get big pay hike, NIH panel says

How one medical school became remarkably diverse

Profiling embryos to choose those with higher IQs is almost a reality

leisure time

FDA early review: GLP

JPM pitch from hospitals? Revenue streams outside of patient care

Stories you might have missed in 2023: health, science, medicine

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Stroke rates rising, especially in working

U.S. death rates show how politics are affecting public health

Wikipedia

explore

focus

focus